Catalina Driscoll

Catalina Driscoll is an accomplished professional in the pharmaceutical industry, currently serving as Global Commercial Development Lead at Alnylam Pharmaceuticals since June 2022. Prior experience includes roles as Executive Director of Global Marketing in Hematology at Vertex Pharmaceuticals, where leadership was provided for the launch of Casgevy, and various strategic positions at Sanofi Genzyme, including Global Head of New Product Planning. Catalina also held marketing roles at Novartis and began a career in the industry at Sanofi as a pharmaceutical sales representative. Academic qualifications include an MBA from MIT Sloan School of Management and a BA in Psychology with a concentration in neuroscience from Amherst College.